Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Grampositive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bact...
Similar Items
-
Prevalence of 16S rRNA methylase genes among β-lactamase-producing Enterobacteriaceae clinical isolates in Saudi Arabia
by: Yazeed A. Al Sheikh, et al.
Published: (2014-07-01) -
Novel mechanism responsible for high-level macrolide resistance in Moraxella catarrhalis
by: Kasai A, et al.
Published: (2018-11-01) -
Mycoplasma genitalium; pregnant women; azithromycin; macrolide resistance; 23S rRNA gene mutations; KwaZulu-Natal.
by: Meleshni Naicker, et al.
Published: (2021-01-01) -
Macrolide Resistance–associated 23S rRNA Mutation in Mycoplasma genitalium, Japan
by: Yasushi Shimada, et al.
Published: (2011-06-01) -
Degradation of 23S rRNA in Azithromycin-Treated Ribonuclease Mutants of <em>Escherichia coli</em>.
by: Silvers, Jessica A.
Published: (2004)